The British pharma giant said Emma Walmsley's current pay could put off candidates for her eventual successor.
For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. | For GSK CEO Emma Walmsley, ...
One of the lowest paid CEOs in pharma—and one of the only woman leading a top-tier giant—is set to receive up to $27.2 ...
Emma Walmsley has also been busy shaking up the company and has replaced 50 top managers, around 40% of the company’s management. Pfizer said in October that it is considering selling its ...
For Big Pharma CEOs, compensation can swing drastically year to year — from base salary to bonus incentives to stock options ...
GlaxoSmithKline (GSK) has appointed its consumer health leader, Emma Walmsley, to take over as CEO when Sir Andrew Witty retires next year. Walmsley has a background in marketing, and joined GSK ...
Fortune curated a list of female leaders at the helm of European companies across the continent’s biggest industries.
Emma Walmsley, CEO of GSK, is nearly eight years into her effort to return the British pharma company to growth, and her work is starting to pay off. Much credit goes to Arexvy, GSK’s first-on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results